{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:25:19Z","timestamp":1793165119251,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107911","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T01:33:39Z","timestamp":1729733619000},"page":"107911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Rationale design and synthesis of new roflumilast analogues as preferential selective and potent PDE-4B inhibitors"],"prefix":"10.1016","volume":"153","author":[{"given":"Ahmed M.","family":"Moussa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Abdelrasheed Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"El-Ashrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa A.","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Al\u2010Karmalawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bioorg.2024.107911_b0005","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1513\/pats.200601-006AW","article-title":"Remodeling in asthma and chronic obstructive pulmonary disease","volume":"3","author":"Postma","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107911_b0010","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13287-022-02938-5","article-title":"Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools","volume":"13","author":"Abbaszadeh","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107911_b0015","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1042\/CS20180316","article-title":"New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease","volume":"133","author":"Brassington","year":"2019","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bioorg.2024.107911_b0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.resp.2018.02.005","article-title":"Is cough important in acute exacerbations of COPD?","volume":"257","author":"Crooks","year":"2018","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.bioorg.2024.107911_b0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejmech.2018.02.038","article-title":"Synthesis and molecular docking of new roflumilast analogues as preferential-selective potent PDE-4B inhibitors with improved pharmacokinetic profile","volume":"148","author":"Moussa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107911_b0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S2213-2600(21)00510-5","article-title":"Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder","volume":"10","author":"Cho","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.bioorg.2024.107911_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.101021","article-title":"Asthma COPD overlap: insights into cellular and molecular mechanisms","volume":"85","author":"Morissette","year":"2022","journal-title":"Mol. Aspects Med."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107911_b0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4025","article-title":"New anti-inflammatory targets for chronic obstructive pulmonary disease","volume":"12","author":"Barnes","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107911_b0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3565(24)37847-4","article-title":"SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor \u03b1 and interleukin-4 production in vivo","volume":"287","author":"Griswold","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107911_b0050","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/01.RES.0000261934.56938.38","article-title":"cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling","volume":"100","author":"Houslay","year":"2007","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107911_b0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/nar\/30.1.245","article-title":"The protein data bank: unifying the archive","volume":"30","author":"Westbrook","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2024.107911_b0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(01)03023-2","article-title":"Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey","volume":"920","author":"Lamontagne","year":"2001","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107911_b0065","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI0215506","article-title":"Deletion of phosphodiesterase 4D in mice shortens \u03b1 2-adrenoceptor\u2013mediated anesthesia, a behavioral correlate of emesis","volume":"110","author":"Robichaud","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107911_b0070","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1073\/pnas.122041599","article-title":"Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-\u03b1 responses","volume":"99","author":"Jin","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107911_b0075","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.4049\/jimmunol.173.12.7531","article-title":"Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation","volume":"173","author":"Ariga","year":"2004","journal-title":"J. Immunol."},{"issue":"9485","key":"10.1016\/j.bioorg.2024.107911_b0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(05)67100-0","article-title":"Roflumilast\u2014an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial","volume":"366","author":"Rabe","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107911_b0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1476-5381.2011.01218.x","article-title":"Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease","volume":"163","author":"Rabe","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.bioorg.2024.107911_b0090","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1016\/j.bmcl.2014.07.016","article-title":"Novel Roflumilast analogs as soft PDE4 inhibitors","volume":"24","author":"Boland","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107911_b0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.rmed.2003.12.012","article-title":"PDE4 inhibitors in COPD\u2014a more selective approach to treatment","volume":"98","author":"Vignola","year":"2004","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107911_b0100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pupt.2010.12.011","article-title":"PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease","volume":"24","author":"Diamant","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2024.107911_b0105","doi-asserted-by":"crossref","unstructured":"J. Taltavull, J. Serrat, J. Gracia, A. Gavalda, M.r. Andr\u00e9s, M. C\u00f3rdoba, M. Miralpeix, D. Vilella, J. Beleta, H. Ryder, Synthesis and biological activity of pyrido [3\u2032, 2\u2032: 4, 5] thieno [3, 2-d] pyrimidines as phosphodiesterase type 4 inhibitors, J. Med. Chem. 53(19) (2010) 6912-6922.","DOI":"10.1021\/jm100524j"},{"issue":"19","key":"10.1016\/j.bioorg.2024.107911_b0110","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1016\/j.bmc.2009.08.014","article-title":"Synthesis and biological evaluation of novel phthalazinone derivatives as topically active phosphodiesterase 4 inhibitors","volume":"17","author":"Kagayama","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107911_b0115","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.bmc.2012.01.033","article-title":"Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure\u2013activity relationships of dual PDE3\/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity","volume":"20","author":"Ochiai","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"5472","key":"10.1016\/j.bioorg.2024.107911_b0120","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1126\/science.288.5472.1822","article-title":"Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity","volume":"288","author":"Xu","year":"2000","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107911_b0125","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107911_b0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.molcel.2004.07.005","article-title":"A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases","volume":"15","author":"Zhang","year":"2004","journal-title":"Mol. Cell"},{"issue":"14","key":"10.1016\/j.bioorg.2024.107911_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411518","article-title":"PDE4 inhibitors: profiling hits through the multitude of structural classes","volume":"24","author":"Jin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107911_b0140","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.bmc.2017.01.047","article-title":"Design, synthesis and biological evaluation of 2, 4-disubstituted oxazole derivatives as potential PDE4 inhibitors","volume":"25","author":"Li","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107911_b0145","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/bip.360330715","article-title":"Modifications of the amide bond and conformational constraints in pseudopeptide analogues","volume":"33","author":"Marraud","year":"1993","journal-title":"Biopolymers"},{"issue":"11","key":"10.1016\/j.bioorg.2024.107911_b0150","first-page":"374","article-title":"Synthesis, characterization and biological studies of 2, 5-substituted 1, 3, 4-thiadiazole carrying 1, 2, 3-triazole core","volume":"6","author":"Kadoor","year":"2014","journal-title":"J. Chem. Pharm. Res."},{"key":"10.1016\/j.bioorg.2024.107911_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104947","article-title":"Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents","volume":"112","author":"El-Metwally","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107911_b0160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/1871520618666180717125906","article-title":"Molecular design and synthesis of new 3, 4-dihydropyrimidin-2 (1H)-ones as potential anticancer agents with VEGFR-2 inhibiting activity","volume":"19","author":"Mostafa","year":"2019","journal-title":"Anticancer Agents Med Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107911_b0165","first-page":"293","article-title":"Synthesis and antitumor activity of some new N-substituted-sulfonyl, 1,2,4-triazole, N-substituted-benzylidene and pyrrole derivatives attached to 4-(benzo [d] thiazol-2-yl) benzohydrazide","volume":"3","author":"El-Hamouly","year":"2011","journal-title":"Der Pharma Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107911_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25051255","article-title":"Synthesis and structure-activity relationship studies of hydrazide-hydrazones as inhibitors of laccase from trametes versicolor","volume":"25","author":"Maniak","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107911_b0175","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1021\/acs.jchemed.5b00954","article-title":"A hydrazine-free Wolff-Kishner reaction suitable for an undergraduate laboratory","volume":"93","author":"Cranwell","year":"2016","journal-title":"J. Chem. Educ."},{"issue":"19","key":"10.1016\/j.bioorg.2024.107911_b0180","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.3390\/ijms221910396","article-title":"Design, synthesis, biological evaluation, 2D-QSAR modeling, and molecular docking studies of novel 1H-3-indolyl derivatives as significant antioxidants","volume":"22","author":"Aziz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107911_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2022.2082533","article-title":"Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity","author":"Hammoud","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2024.107911_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.123039","article-title":"Structural insights into the lead identification of sub-type selective PDE4B inhibitors from plant bioactive molecule analogues","volume":"390","author":"Sharma","year":"2023","journal-title":"J. Mol. Liq."},{"issue":"23","key":"10.1016\/j.bioorg.2024.107911_b0195","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1055\/s-0032-1317527","article-title":"A New route to roflumilast via copper-catalyzed hydroxylation","volume":"44","author":"Ni","year":"2012","journal-title":"Synthesis"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107911_b0200","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100051","article-title":"Design, synthesis, and pharmacological characterization of some 2-substituted-3-phenyl-quinazolin-4 (3H)-one derivatives as phosphodiesterase inhibitors","volume":"354","author":"Amin","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107911_b0205","article-title":"Discovery studio","author":"Studio","year":"2008","journal-title":"Accelrys [2.1]"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107911_b0210","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"Wiley Interdisc. Rev.: Comput. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107911_b0215","unstructured":"C. Inc, Molecular operating environment (MOE), Chemical Computing Group Inc 1010 (2016)."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107911_b0220","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1080\/14756366.2022.2105322","article-title":"Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease","volume":"37","author":"Elagawany","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107911_b0225","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1039\/D1NJ04816C","article-title":"Newly synthesized series of oxoindole\u2013oxadiazole conjugates as potential anti-SARS-CoV-2 agents: in silico and in vitro studies","volume":"46","author":"El-Masry","year":"2022","journal-title":"New J. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107911_b0230","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/antiox11030462","article-title":"Potential valorization of edible nuts by-products: exploring the immune-modulatory and antioxidants effects of selected nut shells extracts in relation to their metabolic profiles","volume":"11","author":"Salem","year":"2022","journal-title":"Antioxidants"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:26:56Z","timestamp":1738204016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824008162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"alternative-id":["S0045206824008162"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107911","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale design and synthesis of new roflumilast analogues as preferential selective and potent PDE-4B inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107911"}}